Granted Patent B2

US 12,377,050 · App. 17/916,618 · Granted Aug 5, 2025

Inventors: Jason G. Auer (Weymouth, MA); Paul Brown (Boston, MA); Tyler L. Carter (Newburyport, MA); Chase Spenser Coffman (Newton, MA); Paul F. Herbert (Framingham, MA); James W. Ivey (Reading, MA); Moin Khwaja (Boston, MA); Lisa Liu (Somerville, MA); Sadiqua Shadbar (Allston, MA); Shankul Vartak (Cambridge, MA)

Assignee: Elektrofi, Inc.

A61K9/1694A61K9/1617A61K9/1623A61K9/1652A61K38/385A61K39/3955A61K41/17B01J13/04

Abstract

Claims (26)

1. A method of forming particles, the method comprising:

a) providing an aqueous first liquid comprising a therapeutic biologic;

b) contacting the aqueous first liquid comprising the therapeutic biologic with an organic second liquid by a continuous process, thereby forming a mixture comprising aqueous liquid droplets, wherein the aqueous liquid droplets comprise the therapeutic biologic;

c) dehydrating the aqueous liquid droplets in the mixture; and

d) removing the aqueous first liquid and organic second liquid from the mixture, thereby forming particles comprising the therapeutic biologic,

wherein the particles comprise less than about 10% internal void spaces and the circularity of the particles is from about 0.80 to about 1.00 after removing the aqueous first liquid and organic second liquid from the mixture,

wherein the concentration of the therapeutic biologic in the aqueous first liquid is from about 10 mg/mL to about 500 mg/mL,

wherein the aqueous first liquid has a viscosity of less than about 10 mPa-s, and

wherein the continuous process of step b), comprises continuous membrane emulsification, continuous homogenization, continuous impinging jet mixing, continuous static mixing, or a combination thereof.

2. The method of claim 1 , wherein the therapeutic biologic is an antibody, antibody fragment, bovine serum albumin (BSA), or human serum albumin (HSA).

3. The method of claim 1 , wherein the aqueous first liquid is water, 0.9% saline, lactated Ringer's solution, a buffer, dextrose 5%, or a combination thereof.

4. The method of claim 1 , wherein the aqueous first liquid further comprises a carbohydrate, a pH adjusting agent, a salt, a chelator, a mineral, a polymer, a protein stabilizer, an emulsifier, an antiseptic, an amino acid, an antioxidant, a protein, an organic solvent, a paraben, a bactericide, a fungicide, a vitamin, a preservative, a nutrient media, an oligopeptide, a biologic excipient, a chemical excipient, a surfactant, or a combination thereof.

5. The method of claim 1 , wherein the organic second liquid is an organic solvent.

6. The method of claim 5 , wherein the organic solvent is acetonitrile, chlorobenzene, chloroform, cyclohexane, cumene, 1,2-dichloroethene, dichloromethane, 1,2-dimethoxyethane, N,N-dimethylacetamide, N,N-dimethylformamide, 1,4-dioxane, 2-ethoxyethanol, ethyleneglycol, formamide, hexane, methanol, 2-methoxyethanol, methylbutyl ketone, methylcyclohexane, methylisobutylketone, N-methylpyrrolidone, nitromethane, pyridine, sulfolane, tetrahydrofuran, tetralin, toluene, 1,1,2-trichloroethene, xylene, acetic acid, acetone, anisole, 1-butanol, 2-butanol, butylacetate, tert-butylmethyl ether, dimethyl sulfoxide, ethanol, ethylacetate, ethyl ether, ethyl formate, formic acid, heptane, isobutylacetate, isopropylacetate, methylacetate, 3-methyl-1-butanol, methylethyl ketone, 2-methyl-1-propanol, pentane, 1-pentanol, 1-propanol, 2-propanol, propylacetate, triethylamine, 1,1-diethoxypropane, 1,1-dimethoxymethane, 2,2-dimethoxypropane, isooctane, isopropyl ether, methylisopropyl ketone, methyltetrahydrofuran, petroleum ether, trichloroacetic acid, trifluoroacetic acid, decanol, 2-ethylhexylacetate, amylacetate, or a combination thereof.

7. The method of claim 1 , wherein the continuous membrane emulsification is conducted by rotating membrane emulsification, cross-flow membrane emulsification, or a combination thereof.

8. The method of claim 1 , wherein the continuous homogenization is conducted by shear homogenization, pressure homogenization, rotor-stator homogenization, microfluidization, or a combination thereof.

9. The method of claim 1 , wherein the continuous static mixing comprises laminar flow, turbulent flow, transition flow, or a combination thereof.

10. The method of claim 1 , wherein the aqueous liquid droplets in the mixture of step c) are dehydrated after contact with the organic second liquid of step b).

11. The method of claim 10 , wherein the dehydration of the aqueous liquid droplets in the mixture of step c) occurs in a continuous drying tube, a continuous drying vessel, or a combination thereof.

12. The method of claim 11 , wherein the continuous drying vessel comprises continuous mechanical stirring.

13. The method of claim 12 , wherein the continuous mechanical stirring is conducted by a turbulent stirred vessel, a magnetic stirring device, or a mechanical stirring device.

14. The method of claim 1 , wherein the aqueous first liquid and organic second liquid from the mixture of step d) are removed through centrifugation, sieving, filtration, solvent exchange, decanting, hydrocyclone separation, or a combination thereof.

15. The method of claim 1 , further comprising washing the particles after step d) with a washing fluid.

16. The method of claim 15 , wherein the washing fluid is an organic liquid, a supercritical fluid, a cryogenic liquid, or a combination thereof.

17. The method of claim 1 , wherein the particles are further dried by lyophilization or vacuum desiccation.

18. The method of claim 1 , wherein the particles are further dried by contacting the particles with a stream of gas.

Assignments (2)

Continuity (2)

References Cited (231)

Cited By (3)

US 12,558,323 US 12,569,445 US 12,600,763